Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 2,970 | 2,920 | 100 | 80 | 2,040 |
| Receivables | 10,950 | 15,280 | 14,730 | 13,500 | 15,560 |
| Inventories | 1,480 | 1,480 | 1,480 | 1,480 | 1,480 |
| Other current assets | 1,870 | 1,600 | 1,810 | 2,310 | 3,380 |
| TOTAL | $17,270 | $21,280 | $18,120 | $17,370 | $22,460 |
| Non-Current Assets | |||||
| Investments And Advances | 1,180 | 410 | 440 | 0 | 250 |
| Other Non-Current Assets | 3,390 | 1,630 | 1,790 | 1,590 | 0 |
| TOTAL | $4,570 | $2,040 | $2,230 | $1,590 | $250 |
| Total Assets | $23,600 | $25,870 | $22,790 | $22,020 | $24,790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 360 | 350 | 320 | 320 | 50 |
| Other current liabilities | 0 | 0 | 0 | 910 | 0 |
| TOTAL | $3,820 | $4,200 | $7,280 | $7,080 | $6,870 |
| Non-Current Liabilities | |||||
| Long Term Debt | 710 | 800 | 2,030 | 4,000 | 5,000 |
| TOTAL | $710 | $800 | $2,030 | $4,000 | $5,000 |
| Total Liabilities | $4,530 | $5,000 | $9,310 | $11,080 | $11,870 |
| Shareholders' Equity | |||||
| Common Shares | 9 | 9 | 7 | 6 | 6 |
| Retained earnings | -5,500 | -1,900 | -1,910 | -2,760 | 380 |
| Other shareholders' equity | -9 | -9 | -7 | -6 | 4 |
| TOTAL | $19,060 | $20,860 | $13,460 | $10,930 | $12,910 |
| Total Liabilities And Equity | $23,590 | $25,860 | $22,770 | $22,010 | $24,780 |